Simultaneous occurrence of chronic myelogenous leukemia and non-Hodgkin lymphoma at diagnosis

Cancer Genetics and Cytogenetics

Volumn 108, Issue 2, 1999, Pages 171-174

  Acar, Hasan ^a   Ecirli, Samil ^a   Gündogan, Fahreddin ^a   Bulay, Orhan ^b   Acar, Aynur ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CHRONIC MYELOID LEUKEMIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; HUMAN; INTERPHASE; LYMPH NODE BIOPSY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; LYMPHOMA, NON-HODGKIN; PREDNISONE; VINCRISTINE;

EID: 0033555308     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00116-2     Document Type: Article

References (13)

1. Athens JW (1993): Chronic myeloid leukemia. Clinical Hematology, 9th Ed. Vol 2. Lea & Febiger, Philadelphia.
2. Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 243:1973;290-293.
3. Kantarjian H., Deisseroth A., Kurzrock R., Estrov Z., Talpaz R. Chronic myelogenous leukemia. a concise update Blood. 82:1993;691-703.
4. Yunis J.J., Oken M.M., Theologiden A., Howe R.B., Kaplan M.E. Recurrent chromosomal defects are found in most patients with non-Hodgkin's lymphoma. Cancer Genet Cytogenet. 13:1984;17-22.
5. Levine E.G., Arthur D.C., Frizzera G., Peterson B.A., Hurd H.D., Bloomfield C.D. There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood. 66:1985;1414-1422.
6. Kristoffersson U., Heim S., Olsson H., Akerman M., Mitelman F. Cytogenetic studies in non-Hodgkin's lymphomas-Results from surgical biopsies. Hereditas. 104:1986;1-13.
7. Weisenburger D.D., Gordon B.G., Vose J.M., Bast M.A., Chan W.C., Greiner T.C., Anderson J.R., Sanger W.G. Occurence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood. 87:1996;3860-3868.
8. Tone L.G., Defavery R., Scrideli C.A., Bernardes L.E., Torres F.M., Soares F.A., Peres L.C., Duarte M.H.O. Translocation (1;5)(q32;q35) in CD30+ anaplastic large cell non-Hodgkin lymphoma of childhood. A case report. Cancer Genet Cytogenet. 86:1996;83-85.
9. Offit K., Jhanwar S.C., Ladanyi M., Fillipa D.A., Chaganti R.S.K. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma. correlation between recurrent aberrations, histology and exposure to cytotoxic treatment Genes Chromosom Cancer. 3:1991;189-201.
10. Johnson C.V., McNeil Carter K.C., Lawrance J.B. A simple rapid technique for prices mapping of multiple sequence in two colors using a single optical filter set. GATA. 8:1991;75-76.
11. Berg J.W. The incidence of multiple primary cancer. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma J Natl Cancer Inst. 38:1967;741-752.
12. Swain W.R., Windschitl H.E., Dosherholmen A., Bankole R.O., Bates A. Chronic myelogenous leukemia in Hodgkins' disease. Cancer. 27:1971;569-573.
13. Boivin J.F., Hutchison G.B., Zauber A.G., Bernstein L., Davis F.G., Michel R.P., Zanke B., Tan C.T., Fuller L.M., Mauch P. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst. 87:1995;705-706.